ArticleTherapeutic advances in gastroenterology2019

Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data.

María Fernanda Guerra Veloz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.